PAK抗体と関連製品
Santa Cruz Biotechnology 社は、様々な細胞プロセスにおける p21 活性化キナーゼ (PAK) を研究するための PAK 抗体の包括的なコレクションを提供しています。PAK Antibodies は、ウェスタンブロッティング（WB）、免疫沈降（IP）、免疫蛍光（IF）、パラフィン包埋切片を用いた免疫組織化学（IHCP）、フローサイトメトリー（FCM）、酵素結合免疫吸着測定法（ELISA）で検証されています。PAKは増殖因子やストレスに対する応答を媒介するシグナル伝達経路に関与しており、癌研究やその他の疾患において重要な標的となっている。PAKの機能を理解することで、様々な病態に対する新たな治療の可能性が見えてくる。研究により、PAKが細胞骨格の動態や細胞接着に影響を及ぼすことが示されている。PAKシグナル伝達ネットワークは正常な細胞発生と組織維持に必須である。最近の研究では、神経疾患や免疫系調節におけるPAKの関与が強調されている。Santa Cruz Biotechnology社のモノクローナル抗体により、研究者はPAK生物学の科学的理解を深め、標的治療法の開発に貢献することができます。
PAK 抗体
| Empty Table Header | 製品名 | CATALOG # | アイソタイプ | エピトープ | アプリケーション | Species | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|---|
α/β/γPAK 抗体 (D-8) | sc-166174 | mouse IgG1 κ | 263-345 (m) | WB, IP, IF, IHC(P), ELISA | m, r, h | 6 | ||
αPAK 抗体 (A-6) | sc-166887 | mouse IgG1 κ | 246-470 (h) | WB, IP, IF, ELISA | m, r, h | 14 | ||
γPAK 抗体 (E-9) | sc-373740 | mouse IgG2b κ | 497-522 (h) | WB, IP, IF, ELISA | m, r, h | 6 | ||
γPAK 抗体 (F-12) | sc-133113 | mouse IgG1 κ | 2-41 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
γPAK 抗体 (G-10) | sc-137208 | mouse IgG1 κ | 2-41 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
γPAK 抗体 (H-4) | sc-377194 | mouse IgG2a κ | 7-43 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
PAK4 抗体 (B-3) | sc-390507 | mouse IgG1 κ | 167-209 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 11 | ||
PAK4 抗体 (B-6) | sc-393367 | mouse IgG1 κ | 101-240 (h) | WB, IP, IF, ELISA | m, r, h | 5 | ||
PAK4 抗体 (6C1) | sc-81532 | mouse IgG1 | (h) | WB, IP | m, r, h and canine | 1 | ||
PAK6 抗体 (H-6) | sc-393075 | mouse IgG2b κ | 71-370 (h) | WB, IP, IF, IHC(P), ELISA | h | 2 | ||
PAK6 抗体 (C-2) | sc-393102 | mouse IgG2a κ | 71-370 (h) | WB, IP, IF, ELISA | h | 1 |
リン酸化型特異的 PAK 抗体
| Empty Table Header | 製品名 | CATALOG # | アイソタイプ | エピトープ | アプリケーション | Species | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|---|
p-αPAK 抗体 (17.Thr 423) | sc-135755 | mouse IgG2b κ | Thr 423 (h) | WB, ELISA | m, r, h | 4 | ||
p-PAK4 抗体 (93.Ser 474) | sc-135775 | mouse IgG2a κ | Ser 474 (h) | WB, IP, IF, IHC(P), ELISA | h | 2 |
PAK CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
αPAK CRISPR/Cas9 KOプラスミド (h2) | sc-400857-KO-2 | h | Gene Knockout | GFP | 1 | ||
αPAK HDRプラスミド (h2) | sc-400857-HDR-2 | h | Homology Directed Repair | Puromycin | 1 | ||
αPAK Double Nickaseプラスミド (h) | sc-400857-NIC | h | Gene Knockout | Puromycin | 1 | ||
αPAK Double Nickaseプラスミド (h2) | sc-400857-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
αPAK Double Nickaseプラスミド (m) | sc-422107-NIC | m | Gene Knockout | Puromycin | 0 | ||
αPAK Double Nickaseプラスミド (m2) | sc-422107-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
βPAK CRISPR/Cas9 KOプラスミド (h) | sc-401109 | h | Gene Knockout | GFP | 0 | ||
βPAK HDRプラスミド (h) | sc-401109-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
βPAK Double Nickaseプラスミド (h) | sc-401109-NIC | h | Gene Knockout | Puromycin | 0 | ||
βPAK Double Nickaseプラスミド (h2) | sc-401109-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
βPAK CRISPR/Cas9 KOプラスミド (m) | sc-422108 | m | Gene Knockout | GFP | 0 | ||
βPAK Double Nickaseプラスミド (m) | sc-422108-NIC | m | Gene Knockout | Puromycin | 0 | ||
βPAK Double Nickaseプラスミド (m2) | sc-422108-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
γPAK CRISPR/Cas9 KOプラスミド (h) | sc-401595 | h | Gene Knockout | GFP | 0 | ||
γPAK HDRプラスミド (h) | sc-401595-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
γPAK Double Nickaseプラスミド (h) | sc-401595-NIC | h | Gene Knockout | Puromycin | 0 | ||
γPAK Double Nickaseプラスミド (h2) | sc-401595-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
γPAK CRISPR/Cas9 KOプラスミド (m) | sc-432435 | m | Gene Knockout | GFP | 0 | ||
γPAK HDRプラスミド (m) | sc-432435-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
γPAK Double Nickaseプラスミド (m) | sc-432435-NIC | m | Gene Knockout | Puromycin | 0 | ||
γPAK Double Nickaseプラスミド (m2) | sc-432435-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PAK4 CRISPR/Cas9 KOプラスミド (h) | sc-401895 | h | Gene Knockout | GFP | 2 | ||
PAK4 HDRプラスミド (h) | sc-401895-HDR | h | Homology Directed Repair | Puromycin | 2 | ||
PAK4 Double Nickaseプラスミド (h) | sc-401895-NIC | h | Gene Knockout | Puromycin | 2 | ||
PAK4 Double Nickaseプラスミド (h2) | sc-401895-NIC-2 | h | Gene Knockout | Puromycin | 2 | ||
PAK4 CRISPR/Cas9 KOプラスミド (m) | sc-427750 | m | Gene Knockout | GFP | 0 | ||
PAK4 HDRプラスミド (m) | sc-427750-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PAK4 Double Nickaseプラスミド (m) | sc-427750-NIC | m | Gene Knockout | Puromycin | 0 | ||
PAK4 Double Nickaseプラスミド (m2) | sc-427750-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PAK5 CRISPR/Cas9 KOプラスミド (h) | sc-404073 | h | Gene Knockout | GFP | 0 | ||
PAK5 HDRプラスミド (h) | sc-404073-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PAK5 Double Nickaseプラスミド (h) | sc-404073-NIC | h | Gene Knockout | Puromycin | 0 | ||
PAK5 Double Nickaseプラスミド (h2) | sc-404073-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PAK5 CRISPR/Cas9 KOプラスミド (m) | sc-433855 | m | Gene Knockout | GFP | 0 | ||
PAK5 HDRプラスミド (m) | sc-433855-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PAK5 Double Nickaseプラスミド (m) | sc-433855-NIC | m | Gene Knockout | Puromycin | 0 | ||
PAK5 Double Nickaseプラスミド (m2) | sc-433855-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PAK6 CRISPR/Cas9 KOプラスミド (h) | sc-403345 | h | Gene Knockout | GFP | 0 | ||
PAK6 HDRプラスミド (h) | sc-403345-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PAK6 Double Nickaseプラスミド (h) | sc-403345-NIC | h | Gene Knockout | Puromycin | 0 | ||
PAK6 Double Nickaseプラスミド (h2) | sc-403345-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PAK6 CRISPR/Cas9 KOプラスミド (m) | sc-431921 | m | Gene Knockout | GFP | 0 | ||
PAK6 HDRプラスミド (m) | sc-431921-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PAK6 Double Nickaseプラスミド (m) | sc-431921-NIC | m | Gene Knockout | Puromycin | 0 | ||
PAK6 Double Nickaseプラスミド (m2) | sc-431921-NIC-2 | m | Gene Knockout | Puromycin | 0 |
PAK CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
αPAK CRISPR Activationプラスミド (h) | sc-400857-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
αPAK CRISPR Activationプラスミド (h2) | sc-400857-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
αPAK Lentiviral Activation Particles (h) | sc-400857-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
αPAK Lentiviral Activation Particles (h2) | sc-400857-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
αPAK CRISPR Activationプラスミド (m) | sc-422107-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
αPAK CRISPR Activationプラスミド (m2) | sc-422107-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
αPAK Lentiviral Activation Particles (m) | sc-422107-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
αPAK Lentiviral Activation Particles (m2) | sc-422107-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK CRISPR Activationプラスミド (h) | sc-401109-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK CRISPR Activationプラスミド (h2) | sc-401109-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK Lentiviral Activation Particles (h) | sc-401109-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK Lentiviral Activation Particles (h2) | sc-401109-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK CRISPR Activationプラスミド (m) | sc-422108-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK CRISPR Activationプラスミド (m2) | sc-422108-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK Lentiviral Activation Particles (m) | sc-422108-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK Lentiviral Activation Particles (m2) | sc-422108-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK CRISPR Activationプラスミド (h) | sc-401595-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK CRISPR Activationプラスミド (h2) | sc-401595-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK Lentiviral Activation Particles (h) | sc-401595-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK Lentiviral Activation Particles (h2) | sc-401595-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK CRISPR Activationプラスミド (m) | sc-432435-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK CRISPR Activationプラスミド (m2) | sc-432435-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK Lentiviral Activation Particles (m) | sc-432435-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK Lentiviral Activation Particles (m2) | sc-432435-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK4 CRISPR Activationプラスミド (h) | sc-401895-ACT | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
PAK4 CRISPR Activationプラスミド (h2) | sc-401895-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
PAK4 Lentiviral Activation Particles (h) | sc-401895-LAC | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
PAK4 Lentiviral Activation Particles (h2) | sc-401895-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
PAK4 CRISPR Activationプラスミド (m) | sc-427750-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK4 CRISPR Activationプラスミド (m2) | sc-427750-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK4 Lentiviral Activation Particles (m) | sc-427750-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK4 Lentiviral Activation Particles (m2) | sc-427750-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 CRISPR Activationプラスミド (h) | sc-404073-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 CRISPR Activationプラスミド (h2) | sc-404073-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 Lentiviral Activation Particles (h) | sc-404073-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 Lentiviral Activation Particles (h2) | sc-404073-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 CRISPR Activationプラスミド (m) | sc-433855-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 CRISPR Activationプラスミド (m2) | sc-433855-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 Lentiviral Activation Particles (m) | sc-433855-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 Lentiviral Activation Particles (m2) | sc-433855-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 CRISPR Activationプラスミド (h) | sc-403345-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 CRISPR Activationプラスミド (h2) | sc-403345-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 Lentiviral Activation Particles (h) | sc-403345-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 Lentiviral Activation Particles (h2) | sc-403345-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 CRISPR Activationプラスミド (m) | sc-431921-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 CRISPR Activationプラスミド (m2) | sc-431921-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 Lentiviral Activation Particles (m) | sc-431921-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 Lentiviral Activation Particles (m2) | sc-431921-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
PAK siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
αPAK siRNA (h) | sc-29700 | h | Gene Silencing | N/A | 19 | ||
αPAK shRNA プラスミド (h) | sc-29700-SH | h | Gene Silencing | Puromycin | 19 | ||
αPAK shRNA (h) レンチウイルス粒子 | sc-29700-V | h | Gene Silencing | Puromycin | 19 | ||
αPAK siRNA (m) | sc-29701 | m | Gene Silencing | N/A | 1 | ||
αPAK shRNA プラスミド (m) | sc-29701-SH | m | Gene Silencing | Puromycin | 1 | ||
αPAK shRNA (m) レンチウイルス粒子 | sc-29701-V | m | Gene Silencing | Puromycin | 1 | ||
αPAK siRNA (r) | sc-270016 | r | Gene Silencing | N/A | 1 | ||
βPAK siRNA (h) | sc-36181 | h | Gene Silencing | N/A | 1 | ||
βPAK shRNA プラスミド (h) | sc-36181-SH | h | Gene Silencing | Puromycin | 1 | ||
βPAK shRNA (h) レンチウイルス粒子 | sc-36181-V | h | Gene Silencing | Puromycin | 1 | ||
βPAK siRNA (m) | sc-36182 | m | Gene Silencing | N/A | 1 | ||
βPAK shRNA プラスミド (m) | sc-36182-SH | m | Gene Silencing | Puromycin | 1 | ||
βPAK shRNA (m) レンチウイルス粒子 | sc-36182-V | m | Gene Silencing | Puromycin | 1 | ||
γPAK siRNA (h) | sc-36183 | h | Gene Silencing | N/A | 4 | ||
γPAK shRNA プラスミド (h) | sc-36183-SH | h | Gene Silencing | Puromycin | 4 | ||
γPAK shRNA (h) レンチウイルス粒子 | sc-36183-V | h | Gene Silencing | Puromycin | 4 | ||
γPAK siRNA (m) | sc-36184 | m | Gene Silencing | N/A | 1 | ||
γPAK shRNA プラスミド (m) | sc-36184-SH | m | Gene Silencing | Puromycin | 1 | ||
γPAK shRNA (m) レンチウイルス粒子 | sc-36184-V | m | Gene Silencing | Puromycin | 1 | ||
PAK4 siRNA (h) | sc-39060 | h | Gene Silencing | N/A | 9 | ||
PAK4 shRNA プラスミド (h) | sc-39060-SH | h | Gene Silencing | Puromycin | 9 | ||
PAK4 shRNA (h) レンチウイルス粒子 | sc-39060-V | h | Gene Silencing | Puromycin | 9 | ||
PAK4 siRNA (m) | sc-39061 | m | Gene Silencing | N/A | 0 | ||
PAK4 shRNA プラスミド (m) | sc-39061-SH | m | Gene Silencing | Puromycin | 0 | ||
PAK4 shRNA (m) レンチウイルス粒子 | sc-39061-V | m | Gene Silencing | Puromycin | 0 | ||
PAK5 siRNA (h) | sc-39062 | h | Gene Silencing | N/A | 0 | ||
PAK5 shRNA プラスミド (h) | sc-39062-SH | h | Gene Silencing | Puromycin | 0 | ||
PAK5 shRNA (h) レンチウイルス粒子 | sc-39062-V | h | Gene Silencing | Puromycin | 0 | ||
PAK5 siRNA (m) | sc-151996 | m | Gene Silencing | N/A | 0 | ||
PAK5 shRNA プラスミド (m) | sc-151996-SH | m | Gene Silencing | Puromycin | 0 | ||
PAK5 shRNA (m) レンチウイルス粒子 | sc-151996-V | m | Gene Silencing | Puromycin | 0 | ||
PAK6 siRNA (h) | sc-39063 | h | Gene Silencing | N/A | 2 | ||
PAK6 shRNA プラスミド (h) | sc-39063-SH | h | Gene Silencing | Puromycin | 2 | ||
PAK6 shRNA (h) レンチウイルス粒子 | sc-39063-V | h | Gene Silencing | Puromycin | 2 | ||
PAK6 siRNA (m) | sc-44879 | m | Gene Silencing | N/A | 2 | ||
PAK6 shRNA プラスミド (m) | sc-44879-SH | m | Gene Silencing | Puromycin | 2 | ||
PAK6 shRNA (m) レンチウイルス粒子 | sc-44879-V | m | Gene Silencing | Puromycin | 2 |